Novartis is sending 500 jobs to the scrap heap while adding 350 ‘high-tech’ positions for growth
Novartis is taking out the ax again in its ongoing global reorganization, cutting into its R&D group while making room for hundreds of new hires …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.